Financials
- Market Capitalization 375.39 M
- Employee 45
- Founded 2019
- CEO N/A
- Website www.x4pharma.com
- Headquarter Delaware, United States
- FIGI BBG001J1CYH8
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-2
市销率
11.96
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3145 | AVIR Atea Pharmaceuticals, Inc. - common stock | 4.74 USD | +0.85% | 0.00% | +7.73% | +47.66% | 379.33 M USD | ||
| 3147 | ENTA Enanta Pharmaceuticals, Inc. - Common Stock | 13.10 USD | -0.08% | -8.07% | +14.51% | +98.79% | 380.93 M USD | ||
| 3179 | LXEO Lexeo Therapeutics, Inc. - Common Stock | 4.63 USD | +0.22% | -7.40% | -1.91% | +11.30% | 363.56 M USD | ||
| 3207 | VNDA Vanda Pharmaceuticals Inc. - Common Stock | 5.83 USD | -0.34% | -9.05% | -0.85% | +5.42% | 350.59 M USD |